Table 2 Optimal observed dose of each component for individual readouts with SE formulation.
CfaEB (µg) | SLA (µg) | dmLT (µg) | |
|---|---|---|---|
Day 21 serum HAI | 10 | 5 | 0.03 |
Day 35 serum HAI | 10 | 5 | 0.03 |
Day 35 IW HAI | 1.7 | 0.05 | 0.17 |
Day 21 serum LT neutralization | 0.3 | 5 | 1 |
Day 35 serum LT neutralization | 0.3 | 5 | 1 |
Day 35 IW dmLT IgG | 0.3 | 5 | 1 |
Day 35 IW CfaEB IgG | 1.7 | 0.05 | 0.17 |
Bone marrow dmLT ASCs | 10 | 0.05 | 1 |
Bone marrow CfaEB ASCs | 10 | 5 | 1 |